Nuheara IQBuds Max vs Otofonix Encore

The Nuheara IQBuds Max is a budget-priced OTC hearing aid that earns a B grade with a SoundScore of 3.3/5 in our lab testing. Priced at $499, this visible-in-ear device from 2021 ranks #46 of 65 OTC hearing aids tested, placing it in the top 69% of its category. The standout feature of the IQBuds Max is its exceptional music streaming performance, scoring 4.3/5—a strong result that sits 2.38 points above the category average. For users who prioritize audio entertainment alongside hearing assistance, this device delivers notably better streaming fidelity than most OTC alternatives. However, speech performance presents a mixed picture. Speech in quiet scores 2.0/5, falling 0.78 points below the category average. Speech in noise is essentially at par with competitors at 1.5/5, which is above average for the category but low in absolute terms. Own voice comfort also trails the category average by 0.31 points with a score of 2.2/5. Feedback handling scores a solid 3.4/5 in absolute terms, though this falls 1.14 points below the category average. The IQBuds Max is best suited for users who value music and audio streaming quality over speech clarity, particularly those seeking an affordable entry point into amplification. Competing devices in this price range—including the Elehear Beyond (4.34/5) and Apple AirPods Pro 2 (4.04/5)—offer stronger overall sound performance for similar investment.

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.